Where I see patients (1)
Selected research
-
Implantation of engineered adipocytes suppresses tumor progression in cancer models.
Nature biotechnology
-
Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial.
JAMA oncology
-
T cells Instruct Immune Checkpoint Inhibitor Therapy Resistance in Tumors Responsive to IL-1 and TNFα Inflammation.
Cancer immunology research